Literature DB >> 16705158

Insulin-like growth factor I controls a mutually exclusive association of RACK1 with protein phosphatase 2A and beta1 integrin to promote cell migration.

Patrick A Kiely1, Denise O'Gorman, Ken Luong, Dorit Ron, Rosemary O'Connor.   

Abstract

The WD repeat scaffolding protein RACK1 can mediate integration of the insulin-like growth factor I receptor (IGF-IR) and integrin signaling in transformed cells. To address the mechanism of RACK1 function, we searched for regulatory proteins that associate with RACK1 in an IGF-I-dependent manner. The serine threonine phosphatase protein phosphatase 2A (PP2A) was found associated with RACK1 in serum-starved cells, and it dissociated immediately upon stimulation with IGF-I. This dissociation of PP2A from RACK1 and an IGF-I-mediated decrease in cellular PP2A activity did not occur in cells expressing either the serine 1248 or tyrosine 1250/1251 mutants of the IGF-IR that do not interact with RACK1. Recombinant RACK1 could bind to PP2A in vitro and restore phosphatase activity to PP2A from IGF-I-stimulated cells. Ligation of integrins with fibronectin or Matrigel was sufficient to facilitate IGF-I-mediated dissociation of PP2A from RACK1 and also to recruit beta1 integrin as PP2A dissociated. By using TAT-fused N-terminal and C-terminal deletion mutants of RACK1, we determined that both PP2A and beta1 integrin interact in the C terminus of RACK1 within WD repeats 4 to 7. This suggests that integrin ligation displaces PP2A from RACK1. MCF-7 cells overexpressing RACK1 exhibited enhanced motility, which could be reversed by the PP2A inhibitor okadaic acid. Small interfering RNA-mediated suppression of RACK1 also decreased the migratory capacity of DU145 cells. Taken together, our findings indicate that RACK1 enhances IGF-I-mediated cell migration through its ability to exclusively associate with either beta1 integrin or PP2A in a complex at the IGF-IR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16705158      PMCID: PMC1489096          DOI: 10.1128/MCB.01868-05

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

Review 1.  Insulin-like growth factor axis during embryonic development.

Authors:  G J Allan; D J Flint; K Patel
Journal:  Reproduction       Date:  2001-07       Impact factor: 3.906

2.  RACK1 is up-regulated in angiogenesis and human carcinomas.

Authors:  H Berns; R Humar; B Hengerer; F N Kiefer; E J Battegay
Journal:  FASEB J       Date:  2000-12       Impact factor: 5.191

3.  Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activation.

Authors:  Klaus Podar; Yu-Tzu Tai; Boris K Lin; Radha P Narsimhan; Martin Sattler; Takashi Kijima; Ravi Salgia; Deepak Gupta; Dharminder Chauhan; Kenneth C Anderson
Journal:  J Biol Chem       Date:  2001-12-20       Impact factor: 5.157

4.  RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix.

Authors:  Ulrich Hermanto; Cong S Zong; Weiqun Li; Lu-Hai Wang
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

Review 5.  Distinct and overlapping functions of insulin and IGF-I receptors.

Authors:  J Nakae; Y Kido; D Accili
Journal:  Endocr Rev       Date:  2001-12       Impact factor: 19.871

6.  Protein phosphatase 2A and protein kinase Calpha are physically associated and are involved in Pseudomonas aeruginosa-induced interleukin 6 production by mast cells.

Authors:  Robert T M Boudreau; Rafael Garduno; Tong-Jun Lin
Journal:  J Biol Chem       Date:  2001-11-12       Impact factor: 5.157

7.  Integrin alpha 2 beta 1 promotes activation of protein phosphatase 2A and dephosphorylation of Akt and glycogen synthase kinase 3 beta.

Authors:  Johanna Ivaska; Liisa Nissinen; Nina Immonen; John E Eriksson; Veli-Matti Kähäri; Jyrki Heino
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

8.  beta1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts.

Authors:  Hira Lal Goel; Michael Breen; Jianzhong Zhang; Ishita Das; Sadie Aznavoorian-Cheshire; Norman M Greenberg; Ada Elgavish; Lucia R Languino
Journal:  Cancer Res       Date:  2005-08-01       Impact factor: 12.701

9.  Site-directed perturbation of protein kinase C- integrin interaction blocks carcinoma cell chemotaxis.

Authors:  Maddy Parsons; Melanie D Keppler; Adam Kline; Anthea Messent; Martin J Humphries; Ruth Gilchrist; Ian R Hart; Corinne Quittau-Prevostel; William E Hughes; Peter J Parker; Tony Ng
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

10.  The WD protein Rack1 mediates protein kinase C and integrin-dependent cell migration.

Authors:  C S Buensuceso; D Woodside; J L Huff; G E Plopper; T E O'Toole
Journal:  J Cell Sci       Date:  2001-05       Impact factor: 5.285

View more
  43 in total

1.  EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex.

Authors:  Guo Li; Xiao-Dan Ji; Hong Gao; Jiang-Sha Zhao; Jun-Feng Xu; Zhi-Jian Sun; Yue-Zhen Deng; Shuo Shi; Yu-Xiong Feng; Yin-Qiu Zhu; Tao Wang; Jing-Jing Li; Dong Xie
Journal:  Nat Commun       Date:  2012-02-07       Impact factor: 14.919

Review 2.  PP2A as a master regulator of the cell cycle.

Authors:  Nathan Wlodarchak; Yongna Xing
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-02-24       Impact factor: 8.250

3.  RACK1 regulates Src activity and modulates paxillin dynamics during cell migration.

Authors:  Ashley T Doan; Anna Huttenlocher
Journal:  Exp Cell Res       Date:  2007-05-18       Impact factor: 3.905

4.  Combating resistance to anti-IGFR antibody by targeting the integrin β3-Src pathway.

Authors:  Dong Hoon Shin; Hyo-Jong Lee; Hye-Young Min; Sun Phil Choi; Mi-Sook Lee; Jung Weon Lee; Faye M Johnson; Kapil Mehta; Scott M Lippman; Bonnie S Glisson; Ho-Young Lee
Journal:  J Natl Cancer Inst       Date:  2013-10-03       Impact factor: 13.506

5.  Insulin-like growth factor-1 receptor-targeted therapy for non-small cell lung cancer: a mini review.

Authors:  Ming Yin; Xiaoxiang Guan; Zhongxin Liao; Qingyi Wei
Journal:  Am J Transl Res       Date:  2009-01-30       Impact factor: 4.060

6.  Walleye dermal sarcoma virus Orf B functions through receptor for activated C kinase (RACK1) and protein kinase C.

Authors:  Candelaria C Daniels; Joel Rovnak; Sandra L Quackenbush
Journal:  Virology       Date:  2008-03-17       Impact factor: 3.616

7.  Interaction with receptor for activated C-kinase 1 (RACK1) sensitizes the phosphodiesterase PDE4D5 towards hydrolysis of cAMP and activation by protein kinase C.

Authors:  Rebecca J Bird; George S Baillie; Stephen J Yarwood
Journal:  Biochem J       Date:  2010-11-15       Impact factor: 3.857

Review 8.  The insulin-like growth factor (IGF) receptor type 1 (IGF1R) as an essential component of the signalling network regulating neurogenesis.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2009-08-29       Impact factor: 5.590

9.  Asc1p/RACK1 Connects Ribosomes to Eukaryotic Phosphosignaling.

Authors:  Kerstin Schmitt; Nadine Smolinski; Piotr Neumann; Samantha Schmaul; Verena Hofer-Pretz; Gerhard H Braus; Oliver Valerius
Journal:  Mol Cell Biol       Date:  2017-01-19       Impact factor: 4.272

10.  Extracellular matrix gene expression profiling using microfluidics for colorectal carcinoma stratification.

Authors:  Christopher J Hayes; Catriona M Dowling; Susan Dwane; Mary E McCumiskey; Shona M Tormey; B Anne Merrigan; John C Coffey; Patrick A Kiely; Tara M Dalton
Journal:  Biomicrofluidics       Date:  2016-10-31       Impact factor: 2.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.